PH18102A - 7-bromo-5-(2-halophenyl)-1h-2,3-dihydro-1,4-benzodiazepine compounds,method for their manufacture and pharmaceutical compositions containing them - Google Patents

7-bromo-5-(2-halophenyl)-1h-2,3-dihydro-1,4-benzodiazepine compounds,method for their manufacture and pharmaceutical compositions containing them

Info

Publication number
PH18102A
PH18102A PH27925A PH27925A PH18102A PH 18102 A PH18102 A PH 18102A PH 27925 A PH27925 A PH 27925A PH 27925 A PH27925 A PH 27925A PH 18102 A PH18102 A PH 18102A
Authority
PH
Philippines
Prior art keywords
halophenyl
dihydro
bromo
manufacture
pharmaceutical compositions
Prior art date
Application number
PH27925A
Other languages
English (en)
Inventor
Horst Zeugner
Michael Ruhland
Hans Liepmann
Wolfgang Milkowski
Herbert Musch
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of PH18102A publication Critical patent/PH18102A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D245/06—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PH27925A 1981-09-30 1982-09-29 7-bromo-5-(2-halophenyl)-1h-2,3-dihydro-1,4-benzodiazepine compounds,method for their manufacture and pharmaceutical compositions containing them PH18102A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813138769 DE3138769A1 (de) 1981-09-30 1981-09-30 7-brom-5-(2-halogenphenyl)-1h-2,3-dihydro-1,4- benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
PH18102A true PH18102A (en) 1985-03-20

Family

ID=6142952

Family Applications (1)

Application Number Title Priority Date Filing Date
PH27925A PH18102A (en) 1981-09-30 1982-09-29 7-bromo-5-(2-halophenyl)-1h-2,3-dihydro-1,4-benzodiazepine compounds,method for their manufacture and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US4505908A (ja)
EP (1) EP0075855B1 (ja)
JP (1) JPS5867678A (ja)
AT (1) ATE17123T1 (ja)
AU (1) AU553689B2 (ja)
CA (1) CA1196635A (ja)
DD (1) DD203907A5 (ja)
DE (2) DE3138769A1 (ja)
DK (1) DK156065C (ja)
ES (1) ES8306126A1 (ja)
FI (1) FI68047C (ja)
GR (1) GR77652B (ja)
HU (1) HU189179B (ja)
IE (1) IE53937B1 (ja)
IL (1) IL66890A (ja)
NO (1) NO157698C (ja)
NZ (1) NZ202036A (ja)
PH (1) PH18102A (ja)
PT (1) PT75553B (ja)
ZA (1) ZA827140B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3221402A1 (de) * 1982-06-05 1983-12-08 Kali-Chemie Pharma Gmbh, 3000 Hannover 5-phenyl-1,4-benzodiazepine enthaltende analgetisch wirksame pharmazeutische zubereitungen
BR0014153A (pt) * 1999-08-27 2002-05-07 Procter & Gamble Componentes de intensificação de branqueamento, composições e métodos de lavagem
US6903060B1 (en) 1999-08-27 2005-06-07 Procter & Gamble Company Stable formulation components, compositions and laundry methods employing same
US6825160B1 (en) 1999-08-27 2004-11-30 Procter & Gamble Company Color safe laundry methods employing cationic formulation components
US6821935B1 (en) 1999-08-27 2004-11-23 Procter & Gamble Company Color safe laundry methods employing zwitterionic formulation components
CN1384867A (zh) 1999-08-27 2002-12-11 宝洁公司 稳定性提高的配制组分、使用该组分的组合物和洗衣方法
JP2003508586A (ja) * 1999-08-27 2003-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー 迅速に作用する処方成分、それらの成分を使用する組成物および洗濯方法
US6818607B1 (en) * 1999-08-27 2004-11-16 Procter & Gamble Company Bleach boosting components, compositions and laundry methods
US7109156B1 (en) 1999-08-27 2006-09-19 Procter & Gamble Company Controlled availability of formulation components, compositions and laundry methods employing same
US7169744B2 (en) * 2002-06-06 2007-01-30 Procter & Gamble Company Organic catalyst with enhanced solubility
US7557076B2 (en) * 2002-06-06 2009-07-07 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
US20050113246A1 (en) * 2003-11-06 2005-05-26 The Procter & Gamble Company Process of producing an organic catalyst
AR051659A1 (es) * 2005-06-17 2007-01-31 Procter & Gamble Una composicion que comprende un catalizador organico con compatibilidada enzimatica mejorada
US8752268B2 (en) 2006-05-26 2014-06-17 Abbott Cardiovascular Systems Inc. Method of making stents with radiopaque markers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244869A (en) * 1972-05-03 1981-01-13 Kali-Chemie A.G. Benzodiazepine derivatives and process of making them
DE2520937C3 (de) * 1975-05-10 1978-10-12 Kali-Chemie Ag, 3000 Hannover 7-Brom-1 -methyl^-alkoxymethyl-S-(2-halogenphenyl)-lH-23-dihydro-l,4benzodiazepinderivate, deren Säureadditionssalze und pharmazeutische Präparate
DE2265370C2 (de) * 1972-05-03 1982-12-02 Kali-Chemie Ag, 3000 Hannover 6-Phenyl-1,2,3,4-tetrahydro-1,5-benzodiazocinderivate
DE2353160C2 (de) * 1973-05-02 1986-07-17 Kali-Chemie Ag, 3000 Hannover 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine, ihre Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
ATE17123T1 (de) 1986-01-15
ZA827140B (en) 1983-07-27
EP0075855B1 (de) 1985-12-27
DK431782A (da) 1983-03-31
ES515774A0 (es) 1983-05-01
DK156065B (da) 1989-06-19
NZ202036A (en) 1985-02-28
AU8883882A (en) 1983-04-14
US4505908A (en) 1985-03-19
GR77652B (ja) 1984-09-25
EP0075855A3 (en) 1983-06-15
DK156065C (da) 1989-11-13
FI68047C (fi) 1985-07-10
AU553689B2 (en) 1986-07-24
NO157698C (no) 1988-05-04
IE53937B1 (en) 1989-04-26
DD203907A5 (de) 1983-11-09
ES8306126A1 (es) 1983-05-01
CA1196635A (en) 1985-11-12
EP0075855A2 (de) 1983-04-06
IL66890A (en) 1985-11-29
IE822362L (en) 1983-03-30
PT75553A (en) 1982-10-01
NO823265L (no) 1983-04-05
NO157698B (no) 1988-01-25
PT75553B (en) 1984-12-12
FI823338L (fi) 1983-03-31
DE3268156D1 (en) 1986-02-06
FI823338A0 (fi) 1982-09-29
HU189179B (en) 1986-06-30
DE3138769A1 (de) 1983-04-14
FI68047B (fi) 1985-03-29
JPS5867678A (ja) 1983-04-22
IL66890A0 (en) 1982-12-31
JPH0433791B2 (ja) 1992-06-04

Similar Documents

Publication Publication Date Title
ZA827140B (en) 7-bromo-5-(2-halophenyl)-1h-2,3-dihydro-1,4-benzodiazepine compounds,method for their manufacture and pharmaceutical compositions containing them
EP0551963A3 (en) Use of heterocyclic derivatives for the manufacture of medicaments
ATE10745T1 (de) Imidazodiazepine, verfahren zu ihrer herstellung, sowie diese enthaltende arzneimittel.
DE3576075D1 (de) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ZA815043B (en) Diazepine derivatives,process for their preparation,and pharmaceutical compositions thereof
DK231686A (da) Oxadiazolylimidazobenzodiazepinforbindelse, farmaceutisk praeparat indeholdende samme, fremgangsmaade til fremstilling af forbindelsen og fremgangsmaade til behandling af en centralnervesystemsygdom
NZ217418A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
DE58907706D1 (de) 4,5,7,8-Tetrahydro-6H-thiazolo[5,4-d]azepine, ihre Herstellung und ihre Verwendung als Arzneimittel.
ZA874385B (en) Hydroxypyrazole derivatives,their preparation and their use against microorganism
ATE219082T1 (de) Verfahren zur herstellung von radioaktiv markierten benzodiazepinrezeptor-mitteln und diese enthaltende zubereitung
ATE22081T1 (de) Substituierte thienobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE3363261D1 (en) Use of 5-phenyl-1,4-benzodiazepines for the manufacture of analgesic pharmaceutical compositions
DE3564685D1 (en) 1-oxadethiacephalosporin derivatives and processes for their preparation
US3708592A (en) 2,4-dihydro-6-phenyl-1h-s-triazolo(4,3-a)(1,4)benzodiazepin-1-one compositions and method of treatment
DE3162691D1 (en) 4h-benzo(4,5)cyclohepta(1,2-b)furan derivatives, process for their preparation and their use as medicines
ES8505685A1 (es) Un procedimiento para preparar compuestos de espiro (2h-1,4-benzodioxepin-3(5h)4'-piperidina y -3'-pirrolidina)
ATE51401T1 (de) Pyrrolo(1,2-b>(1,2,5>triazepine, verfahren und zwischenprodukte zu ihrer herstellung und ihre anwendung als arzneimittel.
FR2199991A1 (en) Hydrophilic 1,4-benzodiazepin-2-one derivs - by reaction of benzodiazepinone and haloalkanoylalkanes and deprotection, with sedative, muscle-relaxant and anticonvulsive action
ES2007745A6 (es) Proceddimiento de preparacion de nuevos derivados triazoles ciclicos condensados.
ES8301991A1 (es) Procedimiento para la preparacion de 7-(2,6-dibromo-4-metil-fenil)-2,3-dihidro-imidazo 1,2-a, imidazoles.